American International Group, Inc. Lyra Therapeutics, Inc. Transaction History

American International Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$6.91 - $12.59 $27,398 - $49,919	-3,965 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$10.38 - $15.61 $114 - $171	11 Added 0.28%	3,965 $46,000
Q4 2020 Feb 12, 2021	BUY	$9.28 - $13.88 $13,892 - $20,778	1,497 Added 60.93%	3,954 $45,000
Q3 2020 Nov 04, 2020	SELL	$10.61 - $13.96 $594 - $781	-56 Reduced 2.23%	2,457 $28,000
Q2 2020 Aug 12, 2020	BUY	$10.91 - $18.56 $27,416 - $46,641	2,513 New	2,513 $28,000

44.4M

300K

1.3K

Ticker LYRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,826,400
Market Cap $8.91M
Description
Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.